Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Injectable Anticoagulants market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Injectable Anticoagulants market. Detailed analysis of key players, along with key growth strategies adopted by Injectable Anticoagulants industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Otsuka
Pfizer
The Medicines Company
Genentech (Roche)
Sanofi
Boehringer Ingelheim
Aspen
By Type:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
By End-User:
VTE
ACS/MI
AF
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Injectable Anticoagulants Market
-
1.3 Market Segment by Type
-
1.3.1 China Injectable Anticoagulants Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH) from 2016 to 2027
-
1.3.2 China Injectable Anticoagulants Market Size and Growth Rate of Direct Thrombin Inhibitor (DTI) from 2016 to 2027
-
1.3.3 China Injectable Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Injectable Anticoagulants Market Size and Growth Rate of VTE from 2016 to 2027
-
1.4.2 China Injectable Anticoagulants Market Size and Growth Rate of ACS/MI from 2016 to 2027
-
1.4.3 China Injectable Anticoagulants Market Size and Growth Rate of AF from 2016 to 2027
-
1.4.4 China Injectable Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Injectable Anticoagulants Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Injectable Anticoagulants by Major Types
-
3.4.1 Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH)
-
3.4.2 Market Size and Growth Rate of Direct Thrombin Inhibitor (DTI)
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Injectable Anticoagulants Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Injectable Anticoagulants by Major End-Users
-
4.4.1 Market Size and Growth Rate of Injectable Anticoagulants in VTE
-
4.4.2 Market Size and Growth Rate of Injectable Anticoagulants in ACS/MI
-
4.4.3 Market Size and Growth Rate of Injectable Anticoagulants in AF
-
4.4.4 Market Size and Growth Rate of Injectable Anticoagulants in Other
5 Market Analysis by Regions
-
5.1 China Injectable Anticoagulants Production Analysis by Regions
-
5.2 China Injectable Anticoagulants Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Injectable Anticoagulants Landscape Analysis
-
6.1 North China Injectable Anticoagulants Landscape Analysis by Major Types
-
6.2 North China Injectable Anticoagulants Landscape Analysis by Major End-Users
7 Central China Injectable Anticoagulants Landscape Analysis
-
7.1 Central China Injectable Anticoagulants Landscape Analysis by Major Types
-
7.2 Central China Injectable Anticoagulants Landscape Analysis by Major End-Users
8 South China Injectable Anticoagulants Landscape Analysis
-
8.1 South China Injectable Anticoagulants Landscape Analysis by Major Types
-
8.2 South China Injectable Anticoagulants Landscape Analysis by Major End-Users
9 East China Injectable Anticoagulants Landscape Analysis
-
9.1 East China Injectable Anticoagulants Landscape Analysis by Major Types
-
9.2 East China Injectable Anticoagulants Landscape Analysis by Major End-Users
10 Northeast China Injectable Anticoagulants Landscape Analysis
-
10.1 Northeast China Injectable Anticoagulants Landscape Analysis by Major Types
-
10.2 Northeast China Injectable Anticoagulants Landscape Analysis by Major End-Users
11 Southwest China Injectable Anticoagulants Landscape Analysis
-
11.1 Southwest China Injectable Anticoagulants Landscape Analysis by Major Types
-
11.2 Southwest China Injectable Anticoagulants Landscape Analysis by Major End-Users
12 Northwest China Injectable Anticoagulants Landscape Analysis
-
12.1 Northwest China Injectable Anticoagulants Landscape Analysis by Major Types
-
12.2 Northwest China Injectable Anticoagulants Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Otsuka
-
13.1.1 Otsuka Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 The Medicines Company
-
13.3.1 The Medicines Company Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Genentech (Roche)
-
13.4.1 Genentech (Roche) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Sanofi
-
13.5.1 Sanofi Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Boehringer Ingelheim
-
13.6.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Aspen
-
13.7.1 Aspen Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH) from 2016 to 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of Direct Thrombin Inhibitor (DTI) from 2016 to 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of VTE from 2016 to 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of ACS/MI from 2016 to 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of AF from 2016 to 2027
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Injectable Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Injectable Anticoagulants Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Injectable Anticoagulants
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Injectable Anticoagulants by Different Types from 2016 to 2027
-
Table Consumption Share of Injectable Anticoagulants by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH)
-
Figure Market Size and Growth Rate of Direct Thrombin Inhibitor (DTI)
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Injectable Anticoagulants by Different End-Users from 2016 to 2027
-
Table Consumption Share of Injectable Anticoagulants by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of VTE
-
Figure Market Size and Growth Rate of ACS/MI
-
Figure Market Size and Growth Rate of AF
-
Figure Market Size and Growth Rate of Other
-
Table China Injectable Anticoagulants Production by Regions
-
Table China Injectable Anticoagulants Production Share by Regions
-
Figure China Injectable Anticoagulants Production Share by Regions in 2016
-
Figure China Injectable Anticoagulants Production Share by Regions in 2021
-
Figure China Injectable Anticoagulants Production Share by Regions in 2027
-
Table China Injectable Anticoagulants Consumption by Regions
-
Table China Injectable Anticoagulants Consumption Share by Regions
-
Figure China Injectable Anticoagulants Consumption Share by Regions in 2016
-
Figure China Injectable Anticoagulants Consumption Share by Regions in 2021
-
Figure China Injectable Anticoagulants Consumption Share by Regions in 2027
-
Table North China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table North China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure North China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure North China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure North China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table North China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table North China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure North China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure North China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure North China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table Central China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table Central China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Central China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure Central China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure Central China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table Central China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Central China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure Central China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure Central China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table South China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table South China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure South China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure South China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure South China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table South China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table South China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure South China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure South China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure South China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table East China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table East China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure East China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure East China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure East China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table East China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table East China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure East China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure East China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure East China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table Northeast China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table Northeast China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure Northeast China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure Northeast China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table Northeast China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Northeast China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure Northeast China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure Northeast China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table Southwest China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table Southwest China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure Southwest China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure Southwest China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table Southwest China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Southwest China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure Southwest China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure Southwest China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table Northwest China Injectable Anticoagulants Consumption by Types from 2016 to 2027
-
Table Northwest China Injectable Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Injectable Anticoagulants Consumption Share by Types in 2016
-
Figure Northwest China Injectable Anticoagulants Consumption Share by Types in 2021
-
Figure Northwest China Injectable Anticoagulants Consumption Share by Types in 2027
-
Table Northwest China Injectable Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Northwest China Injectable Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Injectable Anticoagulants Consumption Share by End-Users in 2016
-
Figure Northwest China Injectable Anticoagulants Consumption Share by End-Users in 2021
-
Figure Northwest China Injectable Anticoagulants Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Otsuka
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka
-
Figure Sales and Growth Rate Analysis of Otsuka
-
Figure Revenue and Market Share Analysis of Otsuka
-
Table Product and Service Introduction of Otsuka
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of The Medicines Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Medicines Company
-
Figure Sales and Growth Rate Analysis of The Medicines Company
-
Figure Revenue and Market Share Analysis of The Medicines Company
-
Table Product and Service Introduction of The Medicines Company
-
Table Company Profile and Development Status of Genentech (Roche)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)
-
Figure Sales and Growth Rate Analysis of Genentech (Roche)
-
Figure Revenue and Market Share Analysis of Genentech (Roche)
-
Table Product and Service Introduction of Genentech (Roche)
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Aspen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen
-
Figure Sales and Growth Rate Analysis of Aspen
-
Figure Revenue and Market Share Analysis of Aspen
-
Table Product and Service Introduction of Aspen
-
